BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Au KP, Chan AC. Is living donor liver transplantation justified in high model for end-stage liver disease candidates (35+)? Current Opinion in Organ Transplantation 2019;24:637-43. [DOI: 10.1097/mot.0000000000000689] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Sukowati CHC, Tiribelli C. Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_719] [Reference Citation Analysis]
2 Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, Heneghan MA, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Mehrabi A, Acarli K, Tokat Y, Coker A, Yilmaz S, Karam V, Duvoux C, Lohse AW, Schramm C; all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA). Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry. Am J Transplant 2021. [PMID: 34605157 DOI: 10.1111/ajt.16864] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Patel MS, Ghanekar A, Sayed BA, Sapisochin G, McGilvray I, Raschzok N, Reichman T, Selzner M, Galvin Z, Bhat M, Stunguris J, Ng VL, Lilly L, Selzner N, Cattral MS. Liver Retransplantation Using Living Donor Grafts: A Western Experience. Liver Transpl 2021. [PMID: 34597461 DOI: 10.1002/lt.26314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]